scholarly journals Kinetic Monitoring Of Neuronal Stress Response To Proteostasis Dysfunction

2021 ◽  
Author(s):  
Angel J Santiago-Lopez ◽  
Ken Berglund ◽  
Robert E Gross ◽  
Claire-Anne N Gutekunst

Proteostasis dysfunction and activation of the unfolded protein response (UPR) are characteristic of all major neurodegenerative diseases. Nevertheless, although the UPR and proteostasis dysfunction has been studied in great detail in model organisms like yeast and mammalian cell lines, it has not yet been examined in neurons. In this study, we applied a viral vector-mediated expression of a reporter protein based on a UPR transcription factor, ATF4, and time-lapse fluorescent microscopy to elucidate how mouse primary neurons respond to pharmacological and genetic perturbations to neuronal proteostasis. In in vitro models of endoplasmic reticulum (ER) stress and proteasome inhibition, we used the ATF4 reporter to reveal the time course of the neuronal stress response relative to neurite degeneration and asynchronous cell death. We showed how potential neurodegenerative disease co-factors, ER stress and mutant α-synuclein overexpression, impacted neuronal stress response and overall cellular health. This work therefore introduces a viral vector-based reporter that yields a quantifiable readout suitable for non-cell destructive kinetic monitoring of proteostasis dysfunction in neurons by harnessing ATF4 signaling as part of the UPR activation.

2012 ◽  
Vol 123 (11) ◽  
pp. 635-647 ◽  
Author(s):  
Radko Komers ◽  
Shaunessy Rogers ◽  
Terry T. Oyama ◽  
Bei Xu ◽  
Chao-Ling Yang ◽  
...  

In the present study, we investigated the activity of the thiazide-sensitive NCC (Na+–Cl− co-transporter) in experimental metabolic syndrome and the role of insulin in NCC activation. Renal responses to the NCC inhibitor HCTZ (hydrochlorothiazide), as a measure of NCC activity in vivo, were studied in 12-week-old ZO (Zucker obese) rats, a model of the metabolic syndrome, and in ZL (Zucker lean) control animals, together with renal NCC expression and molecular markers of NCC activity, such as localization and phosphorylation. Effects of insulin were studied further in mammalian cell lines with inducible and endogenous expression of this molecule. ZO rats displayed marked hyperinsulinaemia, but no differences in plasma aldosterone, compared with ZL rats. In ZO rats, natriuretic and diuretic responses to NCC inhibition with HCTZ were enhanced compared with ZL rats, and were associated with a decrease in BP (blood pressure). ZO rats displayed enhanced Thr53 NCC phosphorylation and predominant membrane localization of both total and phosphorylated NCC, together with a different profile in expression of SPAK (Ste20-related proline/alanine-rich kinase) isoforms, and lower expression of WNK4. In vitro, insulin induced NCC phosphorylation, which was blocked by a PI3K (phosphoinositide 3-kinase) inhibitor. Insulin-induced reduction in WNK4 expression was also observed, but delayed compared with the time course of NCC phosphorylation. In summary, we report increased NCC activity in hyperinsulinaemic rodents in conjunction with the SPAK expression profile consistent with NCC activation and reduced WNK4, as well as an ability of insulin to induce NCC stimulatory phosphorylation in vitro. Together, these findings indicate that hyperinsulinaemia is an important driving force of NCC activity in the metabolic syndrome with possible consequences for BP regulation.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 2583-2583
Author(s):  
Thomas Ruckrich ◽  
Jeannette Gogel ◽  
Marianne Kraus ◽  
Huib Ovaa ◽  
Christoph Driessen

Abstract Resistance towards proteasome inhibition by Bortezomib (Velcade®) represents a challenge for myeloma therapy. Its biology has not yet been characterized in detail. We have demonstrated that Bortezomib-sensitive malignant haematopoetic cells can acquire secondary resistance to Bortezomib in vitro. We here present the first analysis of proteasome biology and activity, alternative proteolytic pathways, ubiquitin-specific proteases (USP) and the ER stress response (unfolded protein response, UPR) upstream of the proteasome, as well as in vitro cytotoxicity of conventional cytotoxic drugs, alternative proteasome inhibitors and agents that target the UPR in Bortezomib-resistant (BR) cells, compared to wild type (WT) controls. BR cells had higher activities of all subunits of the constitutive and the immunoproteasome, as deferred from turnover of fluorogenic substrates as well as affinity-labelling of active proteasome subunits in intact cells. This was mirrored by increased levels of proteasomal β1 and β2, but especially β5 polypeptides, implicating a homeostatic system that senses and corrects low proteasome activity in cells chronically exposed to Bortezomib. While the vinylsulfone-type proteasome inhibitor NLVS abrogated detectable proteasome activity in both BR and WT cells, Bortezomib at therapeutic concentrations eliminated proteasomal β1 and β5-type activity only in WT cells, while BR cells retained residual activity. These changes in proteasome biology appear to be the molecular hallmark of required Bortezomib resistance, since no changes were observed between WT and BR cells in alternative cytosolic or lysosomal proteolytic pathways, UPR activity as well as the gross activity pattern of USP. As expected, this translated into sensitivity against cytotoxic drugs in vitro: BR cells were less sensitive towards alternative proteasome inhibitors. However, while the IC50 for pan-proteasome inhibitors was only roughly doubled in BR cells, it was nearly tenfold elevated for the β5-preferring vinylsulfone inhibitor NLVS. By contrast, sensitivity towards anthracyclines or cytotoxicity induced by ER stressors as well as the synergy between proteasome inhibitors and UPR-activators remained unaffected in BR cells. Based on our data, proteasome inhibitors with activity profiles different from that of Bortezomib, alone or in combination with induction of the UPR, may represent an appropriate concept to overcome secondary Bortezomib resistance.


2020 ◽  
Vol 11 ◽  
Author(s):  
José Miguel Vela

Outbreaks of emerging infections, such as COVID-19 pandemic especially, confront health professionals with the unique challenge of treating patients. With no time to discover new drugs, repurposing of approved drugs or in clinical development is likely the only solution. Replication of coronaviruses (CoVs) occurs in a modified membranous compartment derived from the endoplasmic reticulum (ER), causes host cell ER stress and activates pathways to facilitate adaptation of the host cell machinery to viral needs. Accordingly, modulation of ER remodeling and ER stress response might be pivotal in elucidating CoV-host interactions and provide a rationale for new therapeutic, host-based antiviral approaches. The sigma-1 receptor (Sig-1R) is a ligand-operated, ER membrane-bound chaperone that acts as an upstream modulator of ER stress and thus a candidate host protein for host-based repurposing approaches to treat COVID-19 patients. Sig-1R ligands are frequently identified in in vitro drug repurposing screens aiming to identify antiviral compounds against CoVs, including severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Sig-1R regulates key mechanisms of the adaptive host cell stress response and takes part in early steps of viral replication. It is enriched in lipid rafts and detergent-resistant ER membranes, where it colocalizes with viral replicase proteins. Indeed, the non-structural SARS-CoV-2 protein Nsp6 interacts with Sig-1R. The activity of Sig-1R ligands against COVID-19 remains to be specifically assessed in clinical trials. This review provides a rationale for targeting Sig-1R as a host-based drug repurposing approach to treat COVID-19 patients. Evidence gained using Sig-1R ligands in unbiased in vitro antiviral drug screens and the potential mechanisms underlying the modulatory effect of Sig-1R on the host cell response are discussed. Targeting Sig-1R is not expected to reduce dramatically established viral replication, but it might interfere with early steps of virus-induced host cell reprogramming, aid to slow down the course of infection, prevent the aggravation of the disease and/or allow a time window to mature a protective immune response. Sig-1R-based medicines could provide benefit not only as early intervention, preventive but also as adjuvant therapy.


2011 ◽  
Vol 438 (2) ◽  
pp. 369-378 ◽  
Author(s):  
Abdelali Agouni ◽  
Nimesh Mody ◽  
Carl Owen ◽  
Alicja Czopek ◽  
Derek Zimmer ◽  
...  

Obesity is associated with induction of the ER (endoplasmic reticulum)-stress response signalling and insulin resistance. PTP1B (protein tyrosine phosphatase 1B) is a major regulator of adiposity and insulin sensitivity. The aim of the present study was to investigate the role of L-PTP1B (liver-specific PTP1B) in chronically HFD (high-fat diet) and pharmacologically induced (tunicamycin and thapsigargin) ER-stress response signalling in vitro and in vivo. We assessed the effects of ER-stress response induction on hepatic PTP1B expression, and consequences of hepatic-PTP1B deficiency, in cells and mouse liver, on components of ER-stress response signalling. We found that PTP1B protein and mRNA expression levels were up-regulated in response to acute and/or chronic ER stress, in vitro and in vivo. Silencing PTP1B in hepatic cell lines or mouse liver (L-PTP1B−/−) protected against induction of pharmacologically induced and/or obesity-induced ER stress. The HFD-induced increase in CHOP (CCAAT/enhancer-binding protein homologous protein) and BIP (binding immunoglobulin protein) mRNA levels were partially inhibited, whereas ATF4 (activated transcription factor 4), GADD34 (growth-arrest and DNA-damage-inducible protein 34), GRP94 (glucose-regulated protein 94), ERDJ4 (ER-localized DnaJ homologue) mRNAs and ATF6 protein cleavage were completely suppressed in L-PTP1B−/− mice relative to control littermates. L-PTP1B−/− mice also had increased nuclear translocation of spliced XBP-1 (X box-binding protein-1) via increased p85α binding. We demonstrate that the ER-stress response and L-PTP1B expression are interlinked in obesity- and pharmacologically induced ER stress and this may be one of the mechanisms behind improved insulin sensitivity and lower lipid accumulation in L-PTP1B−/− mice.


2020 ◽  
Vol 19 (2) ◽  
pp. 201-209
Author(s):  
Aline R. Lorenzon ◽  
Jusciele Brogin Moreli ◽  
Rafaela de Macedo Melo ◽  
Felipe Yukio Namba ◽  
Anne Cathrine Staff ◽  
...  

Background and Aim: The endoplasmic reticulum (ER) stress response and the unfolded protein response (UPR) are essential cellular mechanisms to ensure the proper functioning of ER in adverse conditions. However, activation of these pathways has also been associated with insulin resistance and cell death in pathological conditions such as diabetes mellitus. In the present study, we investigated whether stromal cell-derived factor 2 (SDF2)—an ER stress-responsive factor—is related to ER response in placental cells exposed to maternal gestational diabetes mellitus (GDM) or to a hyperglycaemic in vitro condition. Objective: The study aimed to investigate the role of SDF2 in BeWo cells , a trophoblast cell line originating from choriocarcinoma , and in placental tissue under hyperglycaemic conditions. Methods: Protein levels of SDF2 and UPR factors, glucose-related protein 78 (GRP78) and eukaryotic initiation factor 2 alpha (elF2 alpha) were evaluated in the placentae of pregnant women diagnosed with GDM and treated by diet-control (insulin was added when necessary). The mRNA expression of SDF2 and UPR factors CHOP and sXBP1 were assessed in cultured BeWo cells challenged with glucose and treated with or without insulin. Results: SDF2 expression was increased in the placentae of GDM women treated with diet. However, its values were similar to those of normoglycemic controls when the GDM women were treated with insulin and diet. BeWo cells cultured with high glucose and insulin showed decreased SDF2 expression, while high glucose increased CHOP and sXBP1 expression, which was then significantly reverted with insulin treatment. Conclusion: Our findings extend the understanding of ER stress and SDF2 expression in placentae exposed to hyperglycaemia, highlighting the relevance of insulin in reducing the levels of ER stress factors in placental cells. Understanding the effect of ER stress partners such as SDF2 on signalling pathways involved in gestation, complicated by hyperglycaemia, is pivotal for basic biomedical research and may lead to new therapeutic possibilities.


2013 ◽  
Vol 33 (suppl_1) ◽  
Author(s):  
Daniel R Goldstein ◽  
Yang Song

Introduction and hypothesis Aging enhances atherosclerosis for unclear reasons. As macrophage apoptosis and endoplasmic reticulum (ER) stress contribute to atherosclerosis, we examined if aging sensitizes these cells to apoptosis during ER stress. Methods and Results Peritoneal macrophages were isolated from young (aged 2-4 months) and aged (aged 16-18 months) mice, exposed to the ER stress inducer tunicamycin (TM) in vitro, and apoptosis was measured by Annexin V staining via fluorescent microscopy. We found that aged macrophages exhibited significantly more apoptosis than young macrophages (see Figure). We next measured key ER stress proteins in macrophages by Western blot to determine the underlying molecular pathways impacted by aging. With aging, we found reduced activation of inositol-requiring enzyme-1 (IRE1α), a key ER stress transducer. We next examined if augmenting activated IRE1α levels in aged macrophages reduced apoptosis during ER stress. We employed siRNA to knock down x-box binding protein 1 (XBP1), a downstream effector of IRE1α, which has been shown to induce feedback activation of IRE1α in hepatocytes. siRNA to XBP1 significantly reduced tunicamycin-induced cell apoptosis in aged macrophages from 26.1±0.408% to 5.48±1.38% (p<0.05) but not in young macrophages. Conclusions Our study has uncovered a novel, age-dependent interaction by which macrophages undergo apoptosis upon ER stress, and suggests that enhancing IRE1α activation will alleviate aging-augmented ER stress and subsequent apoptosis. This novel interaction may have important implications for the pathogenesis of atherosclerosis with aging.


2020 ◽  
Vol 21 (17) ◽  
pp. 6088
Author(s):  
Asier Ruiz ◽  
Jone Zuazo ◽  
Carolina Ortiz-Sanz ◽  
Celia Luchena ◽  
Carlos Matute ◽  
...  

Sephin1 is a derivative of guanabenz that inhibits the dephosphorylation of the eukaryotic initiation factor 2 alpha (eIF2α) and therefore may enhance the integrated stress response (ISR), an adaptive mechanism against different cellular stresses, such as accumulation of misfolded proteins. Unlike guanabenz, Sephin1 provides neuroprotection without adverse effects on the α2-adrenergic system and therefore it is considered a promising pharmacological therapeutic tool. Here, we have studied the effects of Sephin1 on N-methyl-D-aspartic acid (NMDA) receptor signaling which may modulate the ISR and contribute to excitotoxic neuronal loss in several neurodegenerative conditions. Time-course analysis of peIF2α levels after NMDA receptor overactivation showed a delayed dephosphorylation that occurred in the absence of activating transcription factor 4 (ATF4) and therefore independently of the ISR, in contrast to that observed during endoplasmic reticulum (ER) stress induced by tunicamycin and thapsigargin. Similar to guanabenz, Sephin1 completely blocked NMDA-induced neuronal death and was ineffective against AMPA-induced excitotoxicity, whereas it did not protect from experimental ER stress. Interestingly, both guanabenz and Sephin1 partially but significantly reduced NMDA-induced cytosolic Ca2+ increase, leading to a complete inhibition of subsequent calpain activation. We conclude that Sephin1 and guanabenz share common strong anti-excitotoxic properties with therapeutic potential unrelated to the ISR.


Author(s):  
Hao Chen ◽  
Qi Liu ◽  
Dan Yu ◽  
Kundhavai Natchiar ◽  
Chen Zhou ◽  
...  

AbstractRNA N6-methyladenosine (m6A) modification is present in different RNA molecules, including protein-coding mRNAs and non-coding RNAs such as ribosomal RNAs (rRNAs). Previous studies identified m6A in both the 18S and 28S rRNAs, but the roles of these methylation events are poorly understood due to the lack of knowledge of the responsible methyltransferases. Here, we report that mammalian METTL5, a member of a highly conserved methyltransferase family, specifically methylates adenosine 1832 (A1832) in the 18S rRNA in vivo and in vitro. We identify TRMT112 as a near stoichiometric partner of METTL5 important for the enzymatic activity of METTL5. By mapping the positions of translating ribosomes (Ribo-seq), we found translation of multiple stress response-related mRNAs, including Atf4 mRNA, is selectively reduced in the Mettl5 knockout (KO) mouse B16 melanoma cells. Atf4 is a key transcription factor that mediates the Integrated Stress Response (ISR), as exemplified by the Endoplasmic Reticulum (ER) stress. Consistently, transcription of ISR effector genes is reduced in Mettl5 KO cells during ER stress, suggesting a compromised ISR. Our findings reveal a new mechanism that regulates expression of stress response genes and suggest that chemical modifications of ribosomal RNAs may play a key role in selectively impacting translation and possibly ISR.


2015 ◽  
Author(s):  
Joshua E. Allen ◽  
Jo Ishizawa ◽  
Wafik S. El-Deiry ◽  
Michael Andreeff ◽  
Mathew Garnett ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1129-1129
Author(s):  
Ying Liu ◽  
Merav Socolovsky

Abstract The rate of red blood cell production increases up to ten-fold during stress erythropoiesis. We have recently identified stress-responsive CD71highTer119positive early erythroblast subsets in freshly-isolated mouse hematopoietic tissue by flow cytometry. Both the absolute number and relative frequency of these early erythroblast subsets increase dramatically during stress. We have shown that this erythroblast expansion is associated with enhanced erythroblast viability, which is at least in part due to down-regulation of the death-receptor Fas, and its ligand, FasL from early erythroblasts by erythropoietin-receptor (EpoR) signaling (Liu et al., Blood 2006). The anti-apoptotic protein bcl-xL is induced in differentiating erythroid cells in vitro by EpoR and Stat5 signaling (Socolovsky et al., Cell 1999). Bcl-xL is essential for erythroid cell viability and is required for the maintenance of the normal basal hematocrit (Motoyama et al., Science 1995). However, it is unclear whether bcl-xL plays a role in enhancing erythroblast viability during the stress response. Serum factors other than Epo may modulate erythroid bcl-xL levels (Dolznig et al., Oncogene 2006), complicating the interpretation of bcl-xL measurements in cultured erythroid cells in vitro. Therefore, we examined the potential role of bcl-xL in stress erythropoiesis by measuring bcl-xL mRNA directly in CD71highTer119positive early erythroblasts in vivo in a mouse model of stress. We mimicked the effect of acute erythropoietic stress by injecting adult Balb/C mice with a single dose of Epo (50 mg/kg subcutaneously). Control mice were injected with an equal volume of saline. Spleen cells were harvested at 3, 16, 24, 48 and 72 hours post injection, and CD71highTer119positive early erythroblasts were immediately sorted by flow-cytometry. RNA was extracted from these freshly sorted cells and used in quantitative real-time PCR to measure bcl-xL mRNA expression. We normalized the level of bcl-xL mRNA in each sample by expressing it relative to beta-actin mRNA. At least 3 independent experiments were conducted for each time point. In parallel, we measured serum Epo concentration following Epo injection by ELISA. This showed that Epo increased approximately 100 fold by 40 minutes post-injection, reaching a peak by 6 hours and returning to basline levels by 48 hours. We found that bcl-xL mRNA began to increase in spleen early erythroblasts by 3 hours following Epo injection. By 16 hours, bcl-xL mRNA in Epo-injected mice was three-fold higher than in mice injected with saline. Bcl-xL mRNA continued to be elevated, by 2.5 fold, at 24 hours, but declined back to baseline levels by 48 hours. The time course of the increase in splenic early erythroblast bcl-xL mRNA therefore closely parallels the time course of serum Epo. The induction of early erythroblat bcl-xL mRNA suggests it is likely to contribute to the viability of stress-responsive CD71highTer119positive early erythroblasts, and therefore to the increased erythropoietic rate during the stress response.


Sign in / Sign up

Export Citation Format

Share Document